PGF and chronic kidney disease: The sFlt-1/PlGF ratio has been shown to accurately discriminate between CKD [93], APLA and SLE [94]; pre-existing diabetes [95]; and pre-eclampsia and, therefore, prevent iatrogenic preterm delivery in cases where PET is ruled out.